BackNovo Nordisk A/S Overview

Novo Nordisk A/S Intangible Assets

Track Novo Nordisk A/S's intangible assets ($92B) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Intangible Assets
$92.35B
↓ 13.36% YoYΔ $-14.24B vs prior year quarter

Peer trimmed avg / median

Loading

Novo Nordisk A/S Intangible Assets History

Loading

Novo Nordisk A/S vs. peers: Intangible Assets Comparison

Loading

Novo Nordisk A/S Intangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Novo Nordisk A/S (NOV.DE) FAQ

As of the most recent data (September 2026), NOV.DE shows a intangible assets of $92B. That compares with $110B in the prior-year period — down 13.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, NOV.DE's intangible assets is now $92B (was $110B) — a 13.4% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Novo Nordisk A/S is outperforming or lagging.

Tracking NOV.DE's intangible assets over time shows whether Novo Nordisk A/S is scaling, shrinking, or reshaping that part of the business. The current reading is $92B That compares with $110B in the prior-year period — down 13.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this intangible assets page, Stockcircle has Novo Nordisk A/S's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect intangible assets (currently $92B) with ownership activity and broader fundamentals.

Novo Nordisk A/S's intangible assets is $92B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.